Stockwatch: The Biotech Upgrade Cycle
This article was originally published in Scrip
Executive Summary
One of the positive investment attributes of the technology sector is the upgrade cycle. The continual advancements that result in faster speed, longer battery life and more features translate into consumer demand that justifies discarding last year's phone in favour of this year's model. With so many biotech companies coming to the market in the current IPO window, many are developing drugs that are upgrades of those already on the market.